$447 Million is the total value of SECTOR GAMMA AS's 37 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 20.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Buy | GILEAD SCIENCES INC | $52,132,000 | +28.7% | 843,427 | +23.8% | 11.66% | +32.5% |
| INCY | Buy | INCYTE CORP | $34,903,000 | -0.6% | 459,429 | +3.9% | 7.81% | +2.4% |
| MDT | Buy | MEDTRONIC PLC | $26,074,000 | +14.1% | 290,521 | +41.0% | 5.83% | +17.5% |
| CAH | Buy | CARDINAL HEALTH INC | $20,176,000 | -5.7% | 385,988 | +2.3% | 4.51% | -2.9% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $19,855,000 | +13.4% | 532,735 | +34.8% | 4.44% | +16.7% |
| BIIB | Buy | BIOGEN INC | $18,864,000 | +9.3% | 92,497 | +12.9% | 4.22% | +12.6% |
| CI | Buy | CIGNA CORP NEW | $17,467,000 | +24.9% | 66,283 | +13.6% | 3.91% | +28.6% |
| ANTM | Buy | ELEVANCE HEALTH INC | $16,552,000 | +16.1% | 34,300 | +18.2% | 3.70% | +19.6% |
| ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $14,262,000 | +72.1% | 135,749 | +109.5% | 3.19% | +77.2% |
| OGN | Buy | ORGANON & CO | $12,018,000 | +1.3% | 356,089 | +4.8% | 2.69% | +4.3% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $9,433,000 | +46.0% | 33,474 | +35.2% | 2.11% | +50.4% |
| SGEN | New | SEAGEN INC | $8,988,000 | – | 50,795 | +100.0% | 2.01% | – |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $8,723,000 | +41.9% | 105,259 | +32.0% | 1.95% | +46.1% |
| ABT | New | ABBOTT LABS | $5,346,000 | – | 49,205 | +100.0% | 1.20% | – |
| PTCT | Buy | PTC THERAPEUTICS INC | $3,400,000 | +14.1% | 84,864 | +6.3% | 0.76% | +17.4% |
| NVAX | Buy | NOVAVAX INC | $2,845,000 | +0.8% | 55,324 | +44.4% | 0.64% | +3.9% |
| VIR | Buy | VIR BIOTECHNOLOGY INC | $2,807,000 | +36.1% | 110,223 | +37.4% | 0.63% | +40.2% |
| New | EMBECTA CORP | $133,000 | – | 5,246 | +100.0% | 0.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-05
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.